Torigen Pharmaceuticals is focused on veterinary cancer care. Our product, VetiVax, is a revolutionary cancer immunotherapy that uses the patient's own tumor cells to create a personalized treatment which educates the immune system to recognize the tumor as foreign. With over 12 years of supporting research, VetiVax allows for a variety of tumor antigens to be presented to the immune system. This abundant choice increases the likelihood of a successful response.